4
Researchers conducted a systematic review of articles that analyzed the effect of medicine remedies used to treat COVID-19 during pregnancy.

Researchers conducted a systematic review of articles that analyzed the effect of medicine remedies used to treat COVID-19 during pregnancy.

RUDN physician Anna Borisova, in collaboration with colleagues from Italy, used effective searches and classified 123 articles on this research topic. A literature review was conducted by searching databases of medical and biological publications: PubMed, the U.S. National Library of Medicine, and Embase (Elsevier), a biomedical database.

Researchers conducted a search between 1st of January and 5th of May, 2020, using the keywords “COVID-19,” “SARS-CoV-2,” “pregnancy,” and “therapy.” The analysis covered only drugs with presumptive effects on COVID-19 whose safe use during pregnancy has been proven by clinical trials in other infectious diseases. Drugs contraindicated in pregnancy or with unknown side effects were not included in this review.

“Pregnant women are a high-risk group for coronavirus complications. The situation is also complicated by the fact that not all medications can be prescribed to pregnant women due to their possible teratogenic effect on the fetus, which poses new challenges for the development of effective and safe medications for this category of COVID-19 patients”, — Anna Borisova, Ph.D. in Medicine, assistant of the Department of Obstetrics and Gynecology, Institute of Medicine, RUDN.

As a result of the study, scientists identified groups of drugs that can be used to treat COVID-19 during pregnancy, as well as indications for their prescription:

  • Antiviral medications: lopinavir, ritonavir, remdesivir.
  • Antimalarial medications: hydroxychloroquine.
  • Anticoagulants medications: Low-molecular-weight heparin (due to increased risk of thromboembolic complications in patients with COVID-19).
  • Steroids medications: betamethasone (to accelerate fetal lung maturation, since SARS-CoV-2 infection during pregnancy, especially in the third trimester, may increase the risk of premature rupture of fetal membranes and premature birth).
  • Antibacterials medications: amoxicillin, azithromycin, ceftriaxone (must be prescribed only if a bacterial infection is suspected).
  • Metformin and statins (can be used as adjuvant therapy, to reduce the required dose of antiviral medication and, therefore, its side effects).
  • Reconvalescent plasma (antibodies contained in the plasma of convalescents reduce the viral load, the severity of the disease, and improve aeration).
  • Immunomodulators medications, such as tocilizumab.
  • Interferon type I.
Main Publications View all
15 Nov 2017
RUDN University scientists publish results of their scientific researches in highly-recognized in whole world and indexed in international databases journals (Web of Science, Scopus ect.). That, of course, corresponds to the high status of the University and its international recognition. Publications of June-September 2017 ( In Journals of categories Q1-Q3)
2006
Scientific Conferences View all
12 Dec 2024
About 200 participants from Russia and 20 countries met at the National Interdisciplinary Scientific Seminar with International Participation “Law in Medicine. Medicine in Law: Points of Contact”. The subject was “Happy Motherhood: unsolved problems of obstetrics, gynaecology and perinatology”.
138
Similar newsletter View all
20 Apr
A volunteer of the Red Army and head of the veterinary medicine course — Matilda Mityaeva's combat and scientific path

Matilda Pavlovna Mityaeva was born in 1925. In November 1942, she volunteered for frontline duty. She participated in the Great Patriotic War from November 1942 to June 1945 as part of the 53rd Infantry Division of the 475th Infantry Regiment. She was wounded twice.

24
20 Apr
RUDN University Team – the 1st place in the all-russian competitive selection of scientific projects “Technologies for human health”

The team led by Sergey Zyryanov, Head of the Department of General and Clinical Pharmacology, became the winner of the All-Russian competition of scientific projects "Technologies for Human Health".

32
20 Apr
RUDN University Scientific Agenda to 2030: New Programme for R&D and Innovation Activities Development

RUDN University constantly adapts to the changes of the modern world and responds to challenges flexibly. This allows us to keep the standard of a world-class research university. The sphere of science is no exception. Peter Dokukin, Head of the Research Division, presented the updated R&D Programme at the meeting of the RUDN University Academic Council.

23
Similar newsletter View all